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Introduction: In Rwanda, major depressive disorder affects 11.9% of the population and 
up to 35% of genocide survivors. Mental health services remain underutilized due to 
stigma and lack of awareness. Increasing the ability and capacity to diagnose and treat 
mental disorders is considered important to close this gap. We describe the translation, 
validity, and reliability assessment of the Hamilton Depression Rating Scale (HDRS) as a 
diagnostic tool for moderate to severe depression in Rwanda.
Methods: The HDRS-21 was translated by a multi-group taskforce. We validated the 
translation against expert assessment in a comparative study on a sample of patients 
living with depression and of healthy volunteers. Psychometric properties, namely internal 
structure, reliability, and external validity were assessed using confirmatory factor analysis, 
three reliability calculations, and correlation analysis, respectively. Maximized Youden’s 
index was used for determining diagnostic cut-off.
Results: The translated version demonstrated a kappa of 0.93. We enrolled 105 healthy 
volunteers and 105 patients with confirmed mild to severe depression. In the confirmatory 
factor analysis, HDRS had good factor loadings of 0.32–0.80. Reliability coefficients above 
0.92 indicated strong internal consistency. External validity was shown by good sensitivity 
(0.95) and specificity (0.94) to differentiate depression from absence of depression. At a 
cut-off point of 17 for the diagnosis of depression, sensitivity and specificity were both 
0.95 relative to gold standard.
Conclusion: The validated HDRS in Kinyarwanda with diagnostic cut-off provides mental 
healthcare staff with an accurate tool to diagnose moderate to severe depression, enabling 
closure of the diagnosis and treatment gap.
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INTRODUCTION
Depression is consistently ranked as one of the most important 
contributors to disability worldwide, even the single largest 
contributor to global disability in 2015 (World Health 
Organization, 2017). The global prevalence of depression is 
estimated to be  4.4%, with the highest at 5.9% reported among 
women in the African region (World Health Organization, 2017). 
In Rwanda, with nearly 13 million citizens (Worldometer, 2020), 
specifically, depressive disorders were the third cause of disability 
(Institute for Health Metrics and Evaluation, 2019). The burden 
of mental disorders is compounded by the continuing impact 
of the 1994 genocide (Munyandamutsa et  al., 2012; Rugema 
et  al., 2013, 2015; Ng and Harerimana, 2016), not surprisingly, 
as conflict causes extensive mental issues (Lafta, 2016).
Mental health care in Rwanda has a pyramidal structure, 
ensuring decentralized care (GOV.UK, 2017; Ministry of Health 
Republic of Rwanda, 2018) in all public health facilities, ranging 
from primary health centers under supervision of secondary district 
hospitals to tertiary reference hospitals. In 2016, more than 250,000 
mental health consultations were performed, distributed over 
primary to tertiary centers. Depression accounted only for 4.7% 
of all visits (Ministry of Health Republic of Rwanda, 2018).
In a large-scale survey conducted in 2008 with the support 
of the Rwandan Ministry of Health, the prevalence of 
post-traumatic stress disorder and major depressive episodes 
were 26.1 and 22.7%, respectively (Munyandamutsa et al., 2012).
In a recent survey using the Kinyarwandan version of the 
Mini International Neuropsychiatric Interview, it was found that 
major depressive disorder affected 11.9% of the general population 
in Rwanda, with a higher prevalence in persons aged >46  years 
and with lower education. Major depressive disorder amounted 
to 35% among genocide survivors. Despite this high prevalence, 
significant proportions of the population either are not aware 
of the availability of mental health support or do not use the 
available services. While 62% of the population was aware of 
places offering mental health support, only 5.3% used mental 
health services, resulting in a large diagnosis and treatment gap. 
Among the recommended measures to improve mental health, 
increasing the ability and capacity of health personnel to assess 
and treat early symptoms of mental disorders was considered 
important (Rwandan Mental Health survey 2018, unpublished).
Enabling healthcare professionals (HCPs) to identify and 
diagnose depression is an important first step in mental health 
care. In a resource-limited environment with only few specialized 
HCPs, a broad use of scales to screen, diagnose, and follow-up 
depression can contribute to closure of the diagnosis and 
treatment gap (Anderson et al., 2002). The Hamilton Depression 
Rating Scale (HDRS) is a widely used tool to diagnose and 
rate the severity of depression (Williams, 2001; Ruhe et  al., 
2005). The HDRS-21 is composed of 17 diagnostic questions, 
of which eight are scored on a 5-point scale, ranging from 0 
to 4 and nine are scored from 0 to 2. Questions 18–21 further 
qualify the depression (Medscape). The total HDRS score is 
calculated as the sum of the first 17 questions, ranging from 
0 to 52. A score of 7 or less is considered as absence of 
depression, whereas it is generally agreed that a score of 17–23 
represents moderate depression (Zimmerman et  al., 2013). 
It has been used extensively for assessing severity of depression, 
changes over time, and treatment efficacy with high levels of 
internal consistency, inter-rater reliability, and test-retest reliability 
(Williams, 2001; Ruhe et  al., 2005; Trajkovic et  al., 2011).
We describe the translation process of the HDRS-21 for 
use in Rwanda. In many African societies, it is not culturally 
appropriate to ask directly about emotional states such as “Have 
you  been depressed?” and careful wording is required. Also, 
words describing feeling states are sometimes totally absent 
in the indigenous language (Mbewe et al., 2013). Subsequently, 
we  evaluated its psychometric properties in terms of internal 
structure, reliability, and cut-offs for diagnosis of moderate to 
severe depression in a Rwandan population.
MATERIALS AND METHODS
Translation of HDRS-21
The HDRS-21 was translated from French into Kinyarwanda 
by two groups of experts, who are fluent in French, English, 
and Kinyarwanda and are familiar with the HDRS questionnaire: 
one group of three clinical psychologists and one group of 
psychiatrists and psychiatric nurses. First, each group translated 
the HDRS from French to Kinyarwanda. After comparison of 
these two versions, an initial single translation after consensus 
was proposed. Second, both groups were joined by two linguists 
in a workshop to define a final version, which was back-
translated to French by the linguists and compared to the 
original French version. Lastly, the translation groups scored 
each item of the final HDRS-21 Kinyarwanda version compared 
with the original French version, scoring for cultural and 
linguistic clarity. The quality of the translation was measured 
by the inter-rater agreement on the assessment of the linguistic 
and cultural clarity. Agreement was calculated for all 21 questions 
using Cohen’s kappa coefficient (Cohen, 1960; McHugh, 2012).
Validation of the Translated HDRS-21
Study Set-up
Data collection was conducted in Rwanda. This was a comparative 
study on a sample of patients living with depression and of 
healthy volunteers. Data analysis was conducted at Duke University, 
Durham, United  States in 2017. The study was approved by 
the Institutional Review Board of the Kigali University Hospital, 
Rwanda, and participants provided written informed consent.
Study Participants
Individuals with depression were recruited from six healthcare 
and support centers in Rwanda: Neuropsychiatric Hospital 
Ndera, CARAES Neuropsychiatric Center in Butare, TRAC 
(research and treatment center for HIV/AIDS), Association 
Rwandaise des Conseillers en Traumatisme (ARCT, counseling 
organization for trauma), Uyisenga N’Manzi center (community 
center for orphaned children to young adults after the genocide), 
and the Association des Veuves de la Genocide (counseling 
organization for widows following the genocide).
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Individuals attending these centers were invited to participate 
in the study if they were aged ≥18  years and were able to 
communicate clearly. Patients with depression were selected 
based on their medical charts, and if diagnosed with depression 
according to the fourth revision of the American Psychiatric 
Association’s Diagnostic and Statistical Manual (DSM-IV) or 
the tenth revision of the International Classification of Diseases 
and Related Health Problems (ICD-10) criteria by a structured 
HCP-conducted interview.
The control group consisted of healthy volunteers recruited 
at various sites (hospital, university, and health education institute).
Sample Size Calculation
Sample size calculation was estimated using Gorsuch’s rule 
(MacCallum et  al., 1999), which requires a sample size of five 
times the number of questions assessed, a total of 21  in this 
study, resulting in sample sizes of 105 per group. Given that 
the total score only concerns the first 17 questions, we assumed 
this to be  an adequate sample size.
Procedure
The HDRS-21  in Kinyarwanda was administered through a 
semi-structured clinical interview conducted by trained nurses 
and psychologists, trained general practitioners, and trained 
psychiatrists. Severity of depression was based on expert 
assessment by the lead investigator, a trained psychiatrist.
Psychometric Parameters and Statistical Analysis
All analyses were conducted with R Language for Statistical 
Computing (R foundation, Vienna, Austria). Missing data was 
imputed for cases where individual questions were not answered, 
up to three missing item responses. Generated by the mice 
package in the R Language for Statistical Computing, we  used 
15 multiple imputation sets, with the other questions in the 
questionnaire and sociodemographic variables as the sources 
for imputation.
Internal Structure
Confirmatory factor analysis (CFA) was used to test the internal 
structure of the HDRS. Testing was based on a unidimensional 
model, indicating that the score based on all items of the 
HDRS referred to a single construct, depression. Given the 
categorical nature of the data, the weighted least square means 
and variance-adjusted (WLSMV) estimator was used to estimate 
model parameters. The relationship between each item and 
depression was determined by its loading, which corresponds 
to the correlation between the item and depression.
Through the CFA analysis, several indices that provide 
a measure of the goodness-of-fit of the models to the data 
were obtained. The fit indices, and the generally accepted 
reference levels for a good fit (in parentheses), were the 
following: chi-square (X2 and p-value), root mean square 
error of approximation (RMSEA, ≤0.08), Tucker-Lewis index 
(TLI, >0.90), comparative fit index (CFI, ≥0.90), and average 
variance extracted (AVE, >0.50) (Hu and Bentler, 1999; 
Hair et  al., 2005; Kline, 2011).
Reliability
To determine the reliability of the HDRS, its internal consistency 
was evaluated. Internal consistency, which indicates the degree 
to which all items in the instrument refer to the same construct, 
can be  assessed by several coefficients, each with its own 
strengths and limitations (De Vellis, 2003; Padilla and Divers, 
2016). For this study, Cronbach’s alpha, composite reliability 
(CR), and McDonald’s omega coefficient were calculated using 
CFA results.
Validity
The validity of the HDRS as a diagnostic tool was examined 
by evaluating its accuracy in distinguishing between levels of 
depression, in relation to the gold standard expert opinion. 
Sensitivity, specificity, positive predictive values, and negative 
predictive values of the tool were calculated. By plotting 
sensitivity versus specificity across the HDRS scores, receiver 
operator characteristic (ROC) curves were generated and the 
area under the ROC curve (AUC) was calculated. The AUC 
provides a summary measure of the sensitivity and specificity 
of the HDRS, relative to the expert opinion diagnostic, across 
the entire range of scores. The optimal cut-off score for maximum 
discrimination between depressed and non-depressed participants 
was determined from the ROC curves using the Youden index.
RESULTS
Translation
The mean Cohen’s kappa coefficient of the composite score 
of all 21 items was 0.93, indicating a high degree of agreement 
between translators when comparing translated and 
original versions.
Study Participants
Overall, 210 adults participated in the study, divided into two 
groups of 105 participants (Table  1). Of the depressed group, 
26 (24.8%) were recruited at the Neuropsychiatric Hospital 
Ndera, 5 (4.8%) at CARAES Neuropsychiatric Center in Butare, 
14 (13.3%) at TRAC, 5 (4.8%) at ARCT, 10 (9.5%) at Uyisenga 
N’Manzi center, and 45 (42.9%) at the Association des Veuves 
de la Genocide.
Internal Structure
The CFA unidimensional model performed well, showing all items 
with factor loadings ranging from 0.32 to 0.81 for the HDRS 17 
(Figure  1). Item 17 of the HDRS (patient insight into 
TABLE 1 | Depression severity as per expert opinion.
Patient group (n = 105) Control group (n = 105)
Depression severity, n (%)
No depression 0 (0%) 105 (100%)
Mild 14 (13.3%) 0 (0%)
Moderate 0 (0%) 0 (0%)
Severe 91 (86.6%) 0 (0%)
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his/her condition) showed the smallest factor loading, suggesting 
a problem with the item’s performance. Another model that excluded 
item 17 was tested and was also shown to perform well, with 
factor loadings ranging from 0.65 to 0.81 (Figure  1 and Table  2).
Further results of the CFA confirmed that the models show 
a good fit to the data; the goodness-of-fit indices all met the 
criteria standards for adequacy of fit (Table  2).
Reliability
Values obtained for all three reliability coefficients were above 
0.80 for both HDRS 16 and 17 items, indicating strong internal 
consistency (Table  2).
Validity
The translated HDRS was associated with a high sensitivity (0.95) 
and specificity (0.94) in differentiating participants in the control 
group who did not have depression from those in the patient 
group who had moderate to severe depression (Figure  2).
At a cut-off point of 17 for diagnosis of depression, sensitivity 
and specificity were both 0.95 relative to gold standard. 
Positive and negative predictive values were 96.5 and 93% 
respectively, and the AUC was 0.98.
DISCUSSION
This study evaluated the psychometric properties of the 
HDRS-21  in Kinyarwanda and established the optimal cut-off 
for depression at a score of ≥17.
The translation process, using a mixed model including 
specialized HCPs and bilingual experts with multiple iterations, 
allowed us to address cultural sensitivities on depression and 
words describing feeling states. High consistency between the 
French and Kinyarwandan versions was reflected by Cohen’s 
kappa >0.8 and demonstrated excellent inter-group consistency 
of all translated items.
Subsequently, the psychometric properties of the translated 
HDRS were evaluated. Results of the various tests conducted 
to assess these properties support the use of the HDRS as a 
reliable and valid instrument for evaluating depression. Using 
CFA, the internal structure of the HDRS was found to be adequate 
in relation to a single construct, depression, as reported in 
other studies (Williams, 2001; Ruhe et  al., 2005; Trajkovic 
et  al., 2011). For a unidimensional model, all measuring items 
should have acceptable factor loadings. In our analysis, item 
17 was associated with a smaller factor loading relative to the 
other 16 items, suggesting a poorer performance.
FIGURE 1 | Confirmatory factor analysis model for the Hamilton Depression Rating Scale (HDRS) with factor loadings for 17 (top) and 16 items (bottom).  
HDRS, Hamilton Depression Rating Scale.
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Reliability is the ability of an instrument to measure a given 
construct consistently. The most widely used method for evaluating 
the reliability of an instrument is Cronbach’s alpha (Tavakol and 
Dennick, 2011). As a sensitivity analysis, composite reliability 
and McDonald’s omega were also calculated. The strong internal 
consistency of the translated HDRS, with reliability coefficients 
>0.80, suggests that it is a highly reliable tool for assessing depression.
In addition to reliability, another fundamental element in 
the evaluation of a measurement instrument is its validity 
(Tavakol and Dennick, 2011). The validity of the translated 
HDRS was demonstrated by the AUC of 0.98, close to a value 
of 1.0 that indicates a perfectly accurate instrument.
The present study aimed to establish a diagnostic cut-off for 
the HDRS in Kinyarwanda. Based on the Youden index, a cut-off 
point of 17 was deemed optimal with sensitivity 
and specificity >95%. This cut-off for diagnosis is in line with 
similar cut-offs of ≥16 and 18/19 observed in a mixed community/
outpatient sample (Mottram et  al., 2000) and in a Parkinson’s 
disease outpatient setting in Ecuador, respectively (Serrano-Duenas 
and Soledad Serrano, 2008). In disease-specific populations, lower 
cut-offs have been observed for Parkinson’s disease (Leentjens 
et  al., 2000) (≥12 and 15/16) (Naarding et  al., 2002), stroke 
(10/11) (Naarding et  al., 2002), and Alzheimer’s disease (13/14) 
(Naarding et  al., 2002). In our study, only 11 patients had mild 
depression, skewing diagnosis to moderate to severe depression, 
which may have resulted in a high HDRS cut-off. This could 
be  an advantage in settings with limited availability of drugs 
and where priorities for medical treatment need to be set toward 
moderate to severe depression. For example, in the treatment of 
epilepsy, the treatment of depression may not be  suitable for 
patients with minor or mild depression (Rathore et  al., 2014).
The main limitation of the study was the patient sample 
enrolled. First, the sample size according to Gorsuch’s rule 
allowed validation and assessment of its psychometric properties, 
but larger sample sizes have been proposed as well (MacCallum 
et  al., 1999). This may explain the decreased factor loading 
of item 17, with a supplementary analysis using a 16-item 
model excluding item 17 also showing to be  a good fit to 
the data. Until larger studies confirm our findings and validate 
a 16-item HDRS total score, we  recommend to maintain the 
17-item HDRS total score. Second, we recruited at six different 
sites, yet patients with a background of war trauma represented 
more than half of our sample, which may not have been 
representative of the general population. HDRS cut-offs also 
vary by concomitant disease or background and require 
confirmation if used in specific populations. Lastly, our study 
design did not allow for testing of inter‐ and intra-rater reliability. 
These limitations warrant future studies in a larger sample of 
the general population, including intraclass correlation as well 
as confirmation of the observed factor loading for item 17.
Evaluating psychometric properties of screening and assessment 
tools is a necessary process, since even minor issues in wording, 
connotation, and question structure can reduce the cross-cultural 
relevance of the tools (Sweetland et al., 2014). This is particularly 
important since use of these scales by trained nurses and other 
non-specialist staff is pivotal for scaling up mental health care 
in Rwanda and to a broader extent, in low-income countries, 
it increases the number of staff that can provide such care 
(Belkin et al., 2011; Sweetland et al., 2014). In 2012, the Rwandan 
Ministry of Health, in collaboration with Partners in Health, 
adapted a program for primary care nurses providing training 
to participate in the clinical care of people with mental disorders 
(Smith et  al., 2017). In this stepped-up pathway, trained staff 
can participate more and more in screening and triage, 
engagement, follow-up, and monitoring, as well as referral when 
and where required (Sweetland et  al., 2014). Consequently, 
availability of HDRS in Kinyarwanda is an important step 
forward given the high prevalence of depression.
The HDRS is a valuable addition to the armamentarium of 
validated tools in Kinyarwanda such as the Patient Health 
Questionnaire (PHQ)-9, validated for screening for depression, 
and the Center for Epidemiological Studies Depression Scale 
for Children (CES-DC) (Betancourt et  al., 2012), addressing a 
vulnerable population. Although HDRS has also been used for 
TABLE 2 | Goodness-of-fit indices from the confirmatory factor analysis and 
reliability coefficients.
HDRS 16 items HDRS 17 items
Confirmatory factor analysis
X2 (degrees of freedom); 
p-value 147.10 (104); p = 0.01 159.03 (119); p = 0.01
RMSEA (95% CI) 0.05 (0.03, 0.06) 0.04 (0.02, 0.06)
Tucker-Lewis index 0.99 0.99




Factor loading range 0.65–0.81 0.32–0.81
Reliability
Cronbach’s alpha (95% CI) 0.92 (0.91, 0.93) 0.92 (0.90, 0.93)
Composite reliability 0.95 0.95
McDonald’s omega 0.93 0.93
CI, confidence interval; HDRS, Hamilton Depression Rating Scale; RMSEA, root mean 
square error of approximation.
FIGURE 2 | Receiver operator characteristic (ROC) curve for the diagnostic 
ability of the HDRS versus the depression diagnostic classification of each 
participant. est., estimate; HDRS, Hamilton Depression Rating Scale; PV, 
predictive value; ROC, receiver operator characteristic; SE, standard error; 
Sens, sensitivity; Spec, specificity.
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screening for depression (Aben et  al., 2002; Costa et  al., 2016), 
we  believe that the high number of questions and duration of 
administration impair its user-friendliness as a screening tool, 
for which PHQ-9 is available as a validated alternative.
Addressing the recommendation in the Rwandan Mental 
Health survey, the validation of the HDRS in Kinyarwanda 
(the Kinyarwanda version of HDRS can be  accessed online 
here: http://caraesnderahospital.rw/research-2/) provides primary 
and secondary healthcare staff with an accurate tool for diagnosis 
of moderate to severe depression, enabling closure of the 
diagnosis and treatment gap.
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